Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

The surgeon as the most important factor in lymph node harvest during axillary clearance.

Naumann DN, Sintler M.

Anticancer Res. 2013 Sep;33(9):3935-9.

PMID:
24023331
2.

When is a lymph node dissection a lymph node dissection? The number of lymph nodes resected in sentinel and axillary lymph node dissections.

Olaya W, Wong J, Wong J, Morgan J, Kazanjian K, Lum S.

Ann Surg Oncol. 2013 Feb;20(2):627-32. doi: 10.1245/s10434-012-2642-6. Epub 2012 Sep 7.

PMID:
22956069
3.

The Influence of Hospital and Surgeon Factors on the Prevalence of Axillary Lymph Node Evaluation in Ductal Carcinoma In Situ.

Coromilas EJ, Wright JD, Huang Y, Feldman S, Neugut AI, Chen L, Hershman DL.

JAMA Oncol. 2015 Jun;1(3):323-32. doi: 10.1001/jamaoncol.2015.0389.

PMID:
26181180
4.

Discordance of intraoperative frozen section analysis with definitive histology of sentinel lymph nodes in breast cancer surgery: complementary axillary lymph node dissection is irrelevant for subsequent systemic therapy.

Geertsema D, Gobardhan PD, Madsen EV, Albregts M, van Gorp J, de Hooge P, van Dalen T.

Ann Surg Oncol. 2010 Oct;17(10):2690-5. doi: 10.1245/s10434-010-1052-x. Epub 2010 Apr 27.

5.

Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy.

Reitsamer R, Peintinger F, Rettenbacher L, Prokop E.

J Surg Oncol. 2003 Oct;84(2):63-7.

PMID:
14502778
7.

Is there a requirement for axillary lymph node dissection following identification of micro-metastasis or isolated tumour cells at sentinel node biopsy for breast cancer?

Joyce DP, Solon JG, Prichard RS, Power C, Hill AD.

Surgeon. 2012 Dec;10(6):326-9. doi: 10.1016/j.surge.2012.01.003. Epub 2012 Mar 3.

PMID:
22386798
8.

Impact of axillary dissection in women with invasive breast cancer who do not fit the Z0011 ACOSOG trial because of three or more metastatic sentinel lymph nodes.

Bonneau C, Hequet D, Estevez JP, Pouget N, Rouzier R.

Eur J Surg Oncol. 2015 Aug;41(8):998-1004. doi: 10.1016/j.ejso.2015.04.003. Epub 2015 Apr 25.

PMID:
25986854
9.

Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer.

Bilimoria KY, Bentrem DJ, Hansen NM, Bethke KP, Rademaker AW, Ko CY, Winchester DP, Winchester DJ.

J Clin Oncol. 2009 Jun 20;27(18):2946-53. doi: 10.1200/JCO.2008.19.5750. Epub 2009 Apr 13.

PMID:
19364968
10.

Axillary lymph node count is lower after neoadjuvant chemotherapy.

Neuman H, Carey LA, Ollila DW, Livasy C, Calvo BF, Meyer AA, Kim HJ, Meyers MO, Dees EC, Collichio FA, Sartor CI, Moore DT, Sawyer LR, Frank J, Klauber-DeMore N.

Am J Surg. 2006 Jun;191(6):827-9.

PMID:
16720159
11.

Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.

Schulze T, Mucke J, Markwardt J, Schlag PM, Bembenek A.

J Surg Oncol. 2006 Feb 1;93(2):109-19.

PMID:
16425290
12.
13.

CT assessment of breast cancer for pathological involvement of four or more axillary nodes.

Ogino I, Tayama Y, Arai M, Inoue T, Shimizu D, Ishikawa T.

Breast Cancer. 2012 Apr;19(2):125-30. doi: 10.1007/s12282-010-0216-7. Epub 2010 Aug 10.

PMID:
20697857
14.

Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?

Marrazzo A, Taormina P, Gebbiab V, David M, Riili I, Lo Gerfo D, Casà L, Noto A.

Chir Ital. 2007 Sep-Oct;59(5):693-9.

PMID:
18019642
15.

A longitudinal comparison of arm morbidity in stage I-II breast cancer patients treated with sentinel lymph node biopsy, sentinel lymph node biopsy followed by completion lymph node dissection, or axillary lymph node dissection.

Kootstra JJ, Hoekstra-Weebers JE, Rietman JS, de Vries J, Baas PC, Geertzen JH, Hoekstra HJ.

Ann Surg Oncol. 2010 Sep;17(9):2384-94. doi: 10.1245/s10434-010-0981-8. Epub 2010 Mar 11.

16.

Sentinel lymph node biopsy after previous axillary surgery: A review.

Kothari MS, Rusby JE, Agusti AA, MacNeill FA.

Eur J Surg Oncol. 2012 Jan;38(1):8-15. doi: 10.1016/j.ejso.2011.10.003. Epub 2011 Oct 26. Review.

PMID:
22032909
17.

Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with operable breast cancer and positive axillary nodes at initial diagnosis.

Rebollo-Aguirre AC, Gallego-Peinado M, Sánchez-Sánchez R, Pastor-Pons E, García-García J, Chamorro-Santos CE, Menjón-Beltrán S.

Rev Esp Med Nucl Imagen Mol. 2013 Jul-Aug;32(4):240-5. doi: 10.1016/j.remn.2013.03.006. Epub 2013 May 17.

18.

Surgeon specialization and use of sentinel lymph node biopsy for breast cancer.

Yen TW, Laud PW, Sparapani RA, Nattinger AB.

JAMA Surg. 2014 Feb;149(2):185-92. doi: 10.1001/jamasurg.2013.4350.

19.

A prospective feasibility study of sentinel node biopsy by modified Indigocarmine blue dye methods after neoadjuvant chemotherapy for breast cancer.

Kida K, Ishikawa T, Yamada A, Shimizu D, Tanabe M, Sasaki T, Ichikawa Y, Endo I.

Eur J Surg Oncol. 2015 Apr;41(4):566-70. doi: 10.1016/j.ejso.2014.10.066. Epub 2015 Jan 22.

PMID:
25650249
20.

Predictive value of intraoperative touch preparation analysis of sentinel lymph nodes for axillary metastasis in breast cancer.

Mullenix PS, Carter PL, Martin MJ, Steele SR, Scott CL, Walts MJ, Beitler AL.

Am J Surg. 2003 May;185(5):420-4.

PMID:
12727560

Supplemental Content

Support Center